These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34740503)

  • 21. Reply to Takeshi Takahashi's Letter to the Editor re: Hendrik Van Poppel, Monique J. Roobol, Christopher R. Chapple, et al. Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021. Eur Urol 2021;80:703-711: Would You Play a Russian Roulette-type Game of Prostate-specific Antigen Screening on Yourself?
    Van Poppel H; Roobol MJ
    Eur Urol; 2022 Jan; 81(1):e23-e24. PubMed ID: 34756628
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Andrea Necchi, Laura Marandino, Daniele Raggi, et al. Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? Eur Urol 2021;79:713-6.
    Li R; Jain RK; Sexton WJ
    Eur Urol; 2021 Oct; 80(4):e99. PubMed ID: 34364728
    [No Abstract]   [Full Text] [Related]  

  • 23. Re: Sanjay Kulkarni, Guido Barbagli, Deepak Kirpekar, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945-56.
    Bunker CB
    Eur Urol; 2010 Dec; 58(6):e55-6; author reply e57-8. PubMed ID: 20864253
    [No Abstract]   [Full Text] [Related]  

  • 24. Reply to Bora Lee and Jae Heon Kim's Letter to the Editor re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402-7.
    Uren AD; Cotterill N; Harding C; Hillary C; Chapple C; Klaver M; Bongaerts D; Hakimi Z; Abrams P
    Eur Urol; 2018 Jan; 73(1):e15-e16. PubMed ID: 28801128
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100.
    Dev S
    Eur Urol; 2022 Jan; 81(1):e25. PubMed ID: 34663524
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Alba Fiorentino, Angelo Errico, and Marcello Scarcia's Letter to the Editor re: Marco Moschini, Emanuele Zaffuto, Pierre I. Karakiewicz, et al. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Eur Urol 2019;75:319-28: Radiation Therapy Versus Radical Prostatectomy: No Way Out Without a Randomized Trial.
    Moschini M; Zaffuto E; Mattei A; Karakiewicz PI; Shariat SF
    Eur Urol; 2019 Apr; 75(4):e95. PubMed ID: 30509762
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur urol 2008;54:543-62.
    Madersbacher H; Jünemann KP
    Eur Urol; 2009 Dec; 56(6):e48-9; author reply e50-2. PubMed ID: 19767140
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to Juan Pablo Valdevenito, Marcio Augusto Averbeck, Sanjay Sinha, Enrico Finazzi-Agro, and Andrew Gammie's Letter to the Editor re: Karl H. Pang, Riccardo Campi, Salvador Arlandis, et al. Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus 2022;8:1015-30.
    Pang KH; Campi R; Imran Omar M; Harding CK
    Eur Urol Focus; 2023 Jul; 9(4):629-630. PubMed ID: 36737363
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
    Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
    Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Syed A. Hussain, Nuria Porta, Emma Hall, et al. Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial. Eur Urol 2021;79:307-15.
    Sundar S; Symonds P
    Eur Urol; 2021 Aug; 80(2):e49-e50. PubMed ID: 34024651
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol 2008;54:543-62.
    Staskin DR; Oefelein MG
    Eur Urol; 2009 Mar; 55(3):e49-50; author reply e51. PubMed ID: 18829154
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Benoit Peyronnet, Emma Mironska, Christopher Chapple, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol 2019;75:988-1000: Overactive Bladder Symptoms Can Be Caused by Pelvic Organ Prolapse.
    Liedl B; Goeschen K; Wagenlehner F
    Eur Urol; 2019 Oct; 76(4):e105-e106. PubMed ID: 31320122
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjödahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol;2020:533-7.
    Meeks JJ; Dyrsjkøt L; Robertson AG
    Eur Urol; 2020 Dec; 78(6):e230-e231. PubMed ID: 32994066
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Lu Yang, Shi Qiu and Qiang Wei's Letter to the Editor re: Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, et al. Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives. Eur Urol 2016;69:775-87.
    Bayne CE; Williams -B; Chapin BF
    Eur Urol; 2017 Feb; 71(2):e51. PubMed ID: 27461403
    [No Abstract]   [Full Text] [Related]  

  • 35. Reply to Joshua A. Linscott, Angela B. Smith, and Jesse D. Sammon's Letter to the Editor re: Woonyoung Choi, Andrea Ochoa, David J. McConkey, et al. Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Eur Urol 2017;72:354-65.
    Choi W; McConkey D
    Eur Urol; 2018 Apr; 73(4):e104-e105. PubMed ID: 29174465
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Ferdinando Fusco, Mohamed Abdel-Fattah, Christopher R. Chapple, et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol 2017;72:567-91.
    Agur W; Freites J
    Eur Urol; 2018 Mar; 73(3):e54-e55. PubMed ID: 28958828
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Christian Gratzke, Rob van Maanen, Christopher Chapple, et al. Long-term Safety and Efficacy of Combined Mirabegron and Solifenacin Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II). Eur Urol 2018;74:501-9.
    Lee SR; Park BW; Kim JH
    Eur Urol; 2019 Mar; 75(3):e57-e58. PubMed ID: 30327271
    [No Abstract]   [Full Text] [Related]  

  • 38. Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell E.N. Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016.
    Becker REN; Baras A; Bivalacqua TJ
    Eur Urol; 2021 Feb; 79(2):e58-e59. PubMed ID: 33218822
    [No Abstract]   [Full Text] [Related]  

  • 39. Reply to Santhanam Sundar's letter to the editor Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011;59:1009-18.
    Stenzl A; Cowan NC; De Santis M; Kuczyk MA; Merseburger AS; Ribal MJ; Sherif A; Witjes JA; Lebret T
    Eur Urol; 2012 Aug; 62(2):e45-6. PubMed ID: 22579356
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yuen-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9.
    Teoh JY; Murphy DG; van Oort IM; Loeb S; Ribal MJ
    Eur Urol; 2021 Oct; 80(4):e101. PubMed ID: 34315625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.